Correction to "Insulin-like growth factor-1 on cycle day 2 and assisted reproductive techniques outcome: A cross-sectional study" [Int J Reprod BioMed 2023; 21: 139-146].

IF 1.6 Q3 OBSTETRICS & GYNECOLOGY International Journal of Reproductive Biomedicine Pub Date : 2024-10-14 eCollection Date: 2024-08-01 DOI:10.18502/ijrm.v22i8.17131

Fariba Abbasi, Robab Davar, Farimah Shamsi, Saeideh Dashti

引用次数: 0

Abstract

[This corrects the article DOI: 10.18502/ijrm.v21i2.12804.].

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

更正 "周期第 2 天的胰岛素样生长因子-1 与辅助生殖技术的结果：一项横断面研究" [Int J Reprod BioMed 2023; 21: 139-146]。

[此处更正了文章 DOI：10.18502/ijrm.v21i2.12804.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

International Journal of Reproductive Biomedicine OBSTETRICS & GYNECOLOGY-

CiteScore

2.40

自引率

7.70%

发文量

审稿时长

16 weeks

期刊介绍： The International Journal of Reproductive BioMedicine (IJRM), formerly published as "Iranian Journal of Reproductive Medicine (ISSN: 1680-6433)", is an international monthly scientific journal for who treat and investigate problems of infertility and human reproductive disorders. This journal accepts Original Papers, Review Articles, Short Communications, Case Reports, Photo Clinics, and Letters to the Editor in the fields of fertility and infertility, ethical and social issues of assisted reproductive technologies, cellular and molecular biology of reproduction including the development of gametes and early embryos, assisted reproductive technologies in model system and in a clinical environment, reproductive endocrinology, andrology, epidemiology, pathology, genetics, oncology, surgery, psychology, and physiology. Emerging topics including cloning and stem cells are encouraged.